NCT02337309 2018-08-20
SF1126 for Patients With Relapsed or Refractory Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Terminated
New Approaches to Neuroblastoma Therapy Consortium
University of California, San Diego
Semafore Pharmaceuticals